Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.

Itoh A, Ridgway WM.

Immunotargets Ther. 2017 May 19;6:31-38. doi: 10.2147/ITT.S117264. eCollection 2017. Review.

2.

The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential.

Rackov G, Shokri R, De Mon MÁ, Martínez-A C, Balomenos D.

Front Immunol. 2017 May 8;8:493. doi: 10.3389/fimmu.2017.00493. eCollection 2017. Review.

3.

Toll-Interacting Protein in Resolving and Non-Resolving Inflammation.

Kowalski EJA, Li L.

Front Immunol. 2017 May 5;8:511. doi: 10.3389/fimmu.2017.00511. eCollection 2017. Review.

4.

Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.

Chen K, Yuan R, Zhang Y, Geng S, Li L.

J Am Heart Assoc. 2017 Apr 10;6(4). pii: e004078. doi: 10.1161/JAHA.116.004078.

5.

Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.

Watts BA 3rd, George T, Sherwood ER, Good DW.

Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F103-F115. doi: 10.1152/ajprenal.00064.2017. Epub 2017 Mar 29.

PMID:
28356284
6.
7.

Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms.

Klaska IP, Muckersie E, Martin-Granados C, Christofi M, Forrester JV.

Immunology. 2017 Mar;150(3):364-377. doi: 10.1111/imm.12691. Epub 2016 Dec 18.

8.

The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.

Geng S, Chen K, Yuan R, Peng L, Maitra U, Diao N, Chen C, Zhang Y, Hu Y, Qi CF, Pierce S, Ling W, Xiong H, Li L.

Nat Commun. 2016 Nov 8;7:13436. doi: 10.1038/ncomms13436.

9.

Deficiency in Toll-interacting protein (Tollip) skews inflamed yet incompetent innate leukocytes in vivo during DSS-induced septic colitis.

Diao N, Zhang Y, Chen K, Yuan R, Lee C, Geng S, Kowalski E, Guo W, Xiong H, Li M, Li L.

Sci Rep. 2016 Oct 5;6:34672. doi: 10.1038/srep34672.

10.

p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β.

Rackov G, Hernández-Jiménez E, Shokri R, Carmona-Rodríguez L, Mañes S, Álvarez-Mon M, López-Collazo E, Martínez-A C, Balomenos D.

J Clin Invest. 2016 Aug 1;126(8):3089-103. doi: 10.1172/JCI83404. Epub 2016 Jul 18.

11.

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Deng KQ, Wang A, Ji YX, Zhang XJ, Fang J, Zhang Y, Zhang P, Jiang X, Gao L, Zhu XY, Zhao Y, Gao L, Yang Q, Zhu XH, Wei X, Pu J, Li H.

Nat Commun. 2016 Jun 1;7:11432. doi: 10.1038/ncomms11432.

12.

Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.

Stark RJ, Choi H, Koch SR, Fensterheim BA, Lamb FS, Sherwood ER.

Clin Sci (Lond). 2016 Mar;130(6):451-61. doi: 10.1042/CS20150592. Epub 2015 Dec 15.

13.

Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.

Yang NB, Ni SL, Li SS, Zhang SN, Hu DP, Lu MQ.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9062-71. eCollection 2015.

14.

Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.

Murphy MB, Xiong Y, Pattabiraman G, Manavalan TT, Qiu F, Medvedev AE.

J Leukoc Biol. 2015 Dec;98(6):963-74. doi: 10.1189/jlb.2VMA0515-229RR. Epub 2015 Aug 26.

15.

Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.

Murphy M, Xiong Y, Pattabiraman G, Qiu F, Medvedev AE.

J Biol Chem. 2015 Jul 31;290(31):19218-32. doi: 10.1074/jbc.M115.640128. Epub 2015 Jun 16.

16.

Epigenetic Regulation of Tolerance to Toll-Like Receptor Ligands in Alveolar Epithelial Cells.

Neagos J, Standiford TJ, Newstead MW, Zeng X, Huang SK, Ballinger MN.

Am J Respir Cell Mol Biol. 2015 Dec;53(6):872-81. doi: 10.1165/rcmb.2015-0057OC.

17.

Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.

Huang HF, Zeng Z, Wang KH, Zhang HY, Wang S, Zhou WX, Wang ZB, Xu WG, Duan J.

World J Gastroenterol. 2015 Mar 14;21(10):2937-48. doi: 10.3748/wjg.v21.i10.2937.

18.

Innate immune programing by endotoxin and its pathological consequences.

Morris MC, Gilliam EA, Li L.

Front Immunol. 2015 Jan 6;5:680. doi: 10.3389/fimmu.2014.00680. eCollection 2014. Review.

19.

Alteration of lysosome fusion and low-grade inflammation mediated by super-low-dose endotoxin.

Baker B, Geng S, Chen K, Diao N, Yuan R, Xu X, Dougherty S, Stephenson C, Xiong H, Chu HW, Li L.

J Biol Chem. 2015 Mar 6;290(10):6670-8. doi: 10.1074/jbc.M114.611442. Epub 2015 Jan 13.

20.

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract.

Moncayo-Nieto OL, Wilkinson TS, Brittan M, McHugh BJ, Jones RO, Conway Morris A, Walker WS, Davidson DJ, Simpson AJ.

BMJ Open Respir Res. 2014 Sep 11;1(1):e000046. doi: 10.1136/bmjresp-2014-000046. eCollection 2014.

Supplemental Content

Support Center